Johnson & Johnson (JNJ) Reiterated Outperform at Credit Suisse Ahead of ASH
Tweet Send to a Friend
Credit Suisse analyst Matt Miksic reiterated an Outperform rating on Johnson & Johnson (NYSE: JNJ) ahead of the American Society ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
